Parker Albert P 4
4 · Zynerba Pharmaceuticals, Inc. · Filed Feb 17, 2023
Insider Transaction Report
Form 4
Parker Albert P
Chief Legal Officer
Transactions
- Sale
Common Stock
2023-02-15$0.54/sh−3,173$1,719→ 227,018 total
Footnotes (1)
- [F1]This transaction represents shares required to be sold by the Reporting Person to satisfy tax obligations and certain equity plan administrator fees in connection with the vesting of shares of restricted stock. This sale was mandated by the equity plan administrator and does not represent a discretionary trade by the Reporting Person.